Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Unravelling the EU’s parallel drug trade dilemma

The abolition of trade tariffs on goods between European Union (EU) countries has been heralded as a major step towards a European free market. However, in the pharmaceutical industry, while the principle of the free movement of goods allows free trade across EU borders, varied pricing laws have created a market where cheap drugs from one country are resold for much higher prices in others. Dr Nicola Davies reports.

Go Top